Rankings
▼
Calendar
PEPG Q3 2025 Earnings — PepGen Inc. Revenue & Financial Results | Market Cap Arena
PEPG
PepGen Inc.
$435M
Q3 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$339,000
Operating Income
-$19M
Net Income
-$18M
EPS (Diluted)
$-0.52
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$19M
Free Cash Flow
-$19M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$190M
Total Liabilities
$27M
Stockholders' Equity
$163M
Cash & Equivalents
$143M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$339,000
$0
—
Operating Income
-$19M
-$23M
+19.5%
Net Income
-$18M
-$21M
+15.7%
← FY 2025
All Quarters